Bright Minds Biosciences Ownership 2024 | Who Owns Bright Minds Biosciences Now?
Institutional Ownership
3.03%
Insider Ownership
35.48%
Retail Ownership
61.49%
Institutional Holders
7.00
Bright Minds Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ROYAL BANK OF CANADA | - | - | - | -2,413 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -11,801 | -100.00% | - | Sep 30, 2023 |
| ADVISORSHARES INVESTMENTS LLC | - | - | - | -515,315 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -16,723 | -100.00% | - | Sep 30, 2023 |
| CHECCHI CAPITAL ADVISERS, LLC | - | - | - | -14,138 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -2,098 | -100.00% | - | Sep 30, 2023 |
Bright Minds Biosciences's largest institutional shareholder is ROYAL BANK OF CANADA, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ROYAL BANK OF CANADA | - | - | - | -2,413 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -11,801 | -100.00% | - | Sep 30, 2023 |
| ADVISORSHARES INVESTMENTS LLC | - | - | - | -515,315 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -16,723 | -100.00% | - | Sep 30, 2023 |
| CHECCHI CAPITAL ADVISERS, LLC | - | - | - | -14,138 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -2,098 | -100.00% | - | Sep 30, 2023 |
The largest Bright Minds Biosciences shareholder by % of total assets is ROYAL BANK OF CANADA. The company owns 0.00 shares of Bright Minds Biosciences (DRUG), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| UBS GROUP AG | - | - | - | -2,098 | -100.00% | - | Sep 30, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -2,413 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -11,801 | -100.00% | - | Sep 30, 2023 |
| CHECCHI CAPITAL ADVISERS, LLC | - | - | - | -14,138 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -16,723 | -100.00% | - | Sep 30, 2023 |
| ADVISORSHARES INVESTMENTS LLC | - | - | - | -515,315 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Bright Minds Biosciences's largest institutional buyer is UBS GROUP AG. The company purchased -2.10K stocks of DRUG, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADVISORSHARES INVESTMENTS LLC | - | - | - | -515,315 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -16,723 | -100.00% | - | Sep 30, 2023 |
| CHECCHI CAPITAL ADVISERS, LLC | - | - | - | -14,138 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -11,801 | -100.00% | - | Sep 30, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -2,413 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -2,098 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Bright Minds Biosciences's biggest institutional seller is ADVISORSHARES INVESTMENTS LLC. The company sold -0.52M shares of DRUG, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADVISORSHARES INVESTMENTS LLC | - | - | - | -515,315 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -16,723 | -100.00% | - | Sep 30, 2023 |
| CHECCHI CAPITAL ADVISERS, LLC | - | - | - | -14,138 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -11,801 | -100.00% | - | Sep 30, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -2,413 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -2,098 | -100.00% | - | Sep 30, 2023 |
Bright Minds Biosciences's largest sold out institutional shareholder by shares sold is ADVISORSHARES INVESTMENTS LLC, sold -0.52M shares, valued at -, as of undefined.
Bright Minds Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| AdvisorShares Trust | 0.13% | 515,315 | - | - | Mar 28, 2024 |
| AdvisorShares Trust | 0.04% | 176,038 | -12,081 | -6.42% | Mar 28, 2024 |
Bright Minds Biosciences's largest mutual fund holder by % of total assets is "AdvisorShares Trust", owning 515.32K shares, compromising 0.13% of its total assets.
Bright Minds Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 23 | 7 | -22.22% |
| 31 Mar, 23 | 9 | 12.50% |
| 31 Dec, 22 | 8 | -38.46% |
| 30 Sep, 22 | 13 | 44.44% |
| 30 Jun, 22 | 9 | -10.00% |
| 31 Mar, 22 | 10 | 11.11% |
| 31 Dec, 21 | 9 | - |
As of 30 Jun 23, 7 institutions are holding Bright Minds Biosciences's shares, representing a decrease of -22.22% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 23 | 573,688 | -1.70% |
| 31 Mar, 23 | 583,634 | 42.96% |
| 31 Dec, 22 | 408,240 | -1.03% |
| 30 Sep, 22 | 412,509 | -15.33% |
| 30 Jun, 22 | 487,219 | 17.68% |
| 31 Mar, 22 | 414,016 | -54.56% |
| 31 Dec, 21 | 911,097 | - |
Bright Minds Biosciences (DRUG) has 573.69K shares outstanding as of 30 Jun 23, down -1.70% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 23 | 3.03% | 31.90% |
| 31 Mar, 23 | 3.08% | 59.49% |
| 31 Dec, 22 | 2.28% | 20.41% |
| 30 Sep, 22 | 3.34% | 19.80% |
| 30 Jun, 22 | 4.11% | 33.63% |
| 31 Mar, 22 | 3.49% | 5.91% |
| 31 Dec, 21 | 7.69% | - |
As of 30 Jun 23, Bright Minds Biosciences is held by 3.03% institutional shareholders, representing a 31.90% growth compared to 31 Mar 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 23 | 3 | -40.00% |
| 31 Mar, 23 | 5 | 66.67% |
| 31 Dec, 22 | 3 | -62.50% |
| 30 Sep, 22 | 8 | 166.67% |
| 30 Jun, 22 | 3 | -50.00% |
| 31 Mar, 22 | 6 | -33.33% |
| 31 Dec, 21 | 9 | - |
3 institutional shareholders have increased their position in DRUG stock as of 30 Jun 23 compared to 5 in the previous quarter (a -40.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 23 | 2 | - |
| 31 Mar, 23 | - | -100.00% |
| 31 Dec, 22 | 1 | -50.00% |
| 30 Sep, 22 | 2 | 100.00% |
| 30 Jun, 22 | 1 | - |
| 31 Mar, 22 | - | - |
| 31 Dec, 21 | - | - |
2 institutional shareholders have reduced their position in DRUG stock as of 30 Jun 23 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 23 | 7 | -22.22% | 573,688 | -1.70% | 3.03% | 31.90% | 3 | -40.00% | 2 | - |
| 31 Mar, 23 | 9 | 12.50% | 583,634 | 42.96% | 3.08% | 59.49% | 5 | 66.67% | - | -100.00% |
| 31 Dec, 22 | 8 | -38.46% | 408,240 | -1.03% | 2.28% | 20.41% | 3 | -62.50% | 1 | -50.00% |
| 30 Sep, 22 | 13 | 44.44% | 412,509 | -15.33% | 3.34% | 19.80% | 8 | 166.67% | 2 | 100.00% |
| 30 Jun, 22 | 9 | -10.00% | 487,219 | 17.68% | 4.11% | 33.63% | 3 | -50.00% | 1 | - |
| 31 Mar, 22 | 10 | 11.11% | 414,016 | -54.56% | 3.49% | 5.91% | 6 | -33.33% | - | - |
| 31 Dec, 21 | 9 | - | 911,097 | - | 7.69% | - | 9 | - | - | - |
Bright Minds Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. |
| VIRI | Virios Therapeutics, Inc. |
| PHIO | Phio Pharmaceuticals Corp. |
| ADTX | Aditxt, Inc. |
| REVB | Revelation Biosciences, Inc. |
| RNAZ | TransCode Therapeutics, Inc. |
| DRMA | Dermata Therapeutics, Inc. |
| EFTR | eFFECTOR Therapeutics, Inc. |
| IMMX | Immix Biopharma, Inc. |
| CYTO | Altamira Therapeutics Ltd. |
| NRBO | NeuroBo Pharmaceuticals, Inc. |
| PYXS | Pyxis Oncology, Inc. |
| UNCY | Unicycive Therapeutics, Inc. |
| ZURA | Zura Bio Limited |
| ELEV | Elevation Oncology, Inc. |
DRUG Ownership FAQ
Who Owns Bright Minds Biosciences?
Bright Minds Biosciences is owned by institutional shareholders (3.03%), insiders (35.48%), and public (61.49%). The largest institutional shareholder of Bright Minds Biosciences is ROYAL BANK OF CANADA (0% of total shares) and the top mutual fund owner is AdvisorShares Trust (0.13% of total shares).
Who are the major institutional shareholders of Bright Minds Biosciences?
Bright Minds Biosciences's major institutional shareholders are ROYAL BANK OF CANADA, BLACKROCK INC., ADVISORSHARES INVESTMENTS LLC, TWO SIGMA SECURITIES, LLC, and CHECCHI CAPITAL ADVISERS, LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Bright Minds Biosciences shareholders are there?
As of Jun 2023, there are 7 institutional shareholders of Bright Minds Biosciences.
What percentage of Bright Minds Biosciences is owned by ROYAL BANK OF CANADA?
ROYAL BANK OF CANADA owns 0 shares of Bright Minds Biosciences, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).
What percentage of Bright Minds Biosciences is owned by BLACKROCK INC?
As of Sep 2023, BLACKROCK INC holds 0 shares of Bright Minds Biosciences (DRUG), compromising 0% of the company, valued at $0.
What percentage of Bright Minds Biosciences is owned by ADVISORSHARES INVESTMENTS LLC?
ADVISORSHARES INVESTMENTS LLC is the third largest holder of Bright Minds Biosciences. The company owns 0 of the company's shares outstanding (worth $0).